HSBC Holdings
CRL icon

HSBC Holdings’s Charles River Laboratories CRL Stock Holding History

HSBC Holdings’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,522
Closed -$107K – 1968
2015
Q2 		$107K Buy
+1,522
New +$113K ﹤0.01% 1914

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

HSBC Holdings's CRL Position: Q2 2026 in Review

HSBC Holdings reduced its Charles River Laboratories (CRL) stake by 2.7% in Q2 2026, selling an estimated $335K and leaving 67,802 shares worth $15.4M. The position accounts for 0.01% of the portfolio, ranked #840.

HSBC Holdings first reported a position in CRL in Q1 2015 and has held it in 46 quarters since. The position peaked at $20.9M in Q1 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • HSBC Holdings held 67,802 shares of Charles River Laboratories worth $15.4M as of Q2 2026.
  • HSBC Holdings sold 1,880 Charles River Laboratories shares in Q2 2026, an estimated $335K.
  • Charles River Laboratories made up 0.01% of HSBC Holdings's portfolio in Q2 2026, its #840 holding.
  • HSBC Holdings first reported a position in Charles River Laboratories in Q1 2015 and has held it in 46 quarters since.
  • HSBC Holdings's Charles River Laboratories position peaked at $20.9M in Q1 2024.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.